Successful prophylaxis using activated prothrombin complex concentrates (aPCC) in a severe haemophilia A patient with inhibitor previously unresponsive to on-demand daily infusions of aPCC

Haemophilia. 2017 Sep;23(5):e481-e484. doi: 10.1111/hae.13310. Epub 2017 Aug 3.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Blood Coagulation Factors / administration & dosage
  • Blood Coagulation Factors / pharmacology
  • Blood Coagulation Factors / therapeutic use*
  • Child
  • Hemophilia A / complications
  • Hemophilia A / drug therapy*
  • Hemophilia A / immunology*
  • Hemorrhage / complications*
  • Hemorrhage / prevention & control*
  • Humans
  • Isoantibodies / immunology
  • Male
  • Treatment Failure

Substances

  • Blood Coagulation Factors
  • Isoantibodies
  • prothrombin complex concentrates